ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

QC Kinetix Franchise Specializing in Regenerative Medicine Ranks on Prestigious Franchise List

CHARLOTTE, NC / ACCESSWIRE / July 19, 2022 / QC Kinetix, a medical franchise specializing in regenerative medicine, is excited to be included in the recently released Entrepreneur's Top 150 Hottest New Brands List. The list shines the light on some of the newest rising stars in the franchise world. The ranking consists of those companies that began franchising in the last five years.

QC Kinetix, Tuesday, July 19, 2022, Press release picture

Entreprenuer's Franchise 500 evaluation of new and emerging franchises analyzes more than 150 data points consisting of costs and fees, size and growth, franchisee support, brand support, brand strength, and financial strength and stability.

QC Kinetix CEO Scott Hoots is proud of the growth of the brand.

"In a short amount of time, our franchise has made a significant impact in the communities where we provide services. We have truly been able to make a difference in people's lives by reducing pain through the life-changing regenerative medicine treatments we offer."

QC Kinetix provides effective, non-surgical treatments for musculoskeletal conditions, to improve patients' lives. Each patient receives individualized care tailored to their unique situation.

Using the latest in natural, regenerative therapies, treatments have proven effective for countless patients suffering from joint inflammation, chronic pain, or a lack of mobility.

The brand continues to expand, now providing a new line of dietary supplements in addition to a recently unveiled hair restoration therapy designed to enhance hair growth.

QC Kinetix is plotting international expansion, starting with the United Kingdom, New Zealand, Australia, Spain, and Sweden - locations familiar with the benefits of regenerative medicine.

The global regenerative medicine industry is expected to reach $83.2 billion by 2030, according to an Allied Market Research report, driven largely by a greater focus on improving health.

Media Contacts:

Jennifer Williams jwilliams@919marketing.com 919.459.3592
Sue Yannello syannello@919marketing.com 919.459.8162

About QC Kinetix

QC Kinetix is a Charlotte, North Carolina-based franchise company leading the way in helping people maintain an active lifestyle using comprehensive regenerative medicine treatments to address musculoskeletal conditions and joint pain. QC Kinetix uses the body's own healing properties through state-of-the-art natural biologic treatments as alternatives to invasive surgery and addictive pain medications. The healthcare franchise currently operates in more than cities with rapid growth underway throughout the U.S. QC Kinetix clinics are dedicated to maximizing the body's ability to help heal and repair itself from the inside out for vastly improved function and overall quality of life. For more information, visit www.qckinetix.com.

SOURCE: QC Kinetix



View source version on accesswire.com:
https://www.accesswire.com/708981/QC-Kinetix-Franchise-Specializing-in-Regenerative-Medicine-Ranks-on-Prestigious-Franchise-List

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.